Depression and Anxiety Trial, Recruiting NCT06934330 Sponsor: Sha Research Foundation Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06934330
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 19 or older who have been diagnosed with unipolar depression (a form of depression without manic episodes) by a licensed doctor, based on recognised international diagnostic standards
  • People who are willing and able to take part in data collection as required by the study
  • People who are willing to sign consent forms and allow their relevant information to be shared before the study begins
  • People who are willing to allow their data to be used for research and publication by the Sha Research Foundation, in line with privacy laws
  • People who are willing to practise daily mindfulness exercises for at least 30 minutes each day and follow the study's guidelines

Who may not be able to join:

  • People who do not meet the inclusion criteria listed above
  • People who have been diagnosed with bipolar disorder or schizophrenia (a condition involving psychosis or breaks from reality)
  • People who are currently being treated with a strong type of antipsychotic medication known as highly potent neuroleptics
  • People who are unwilling to take part in data collection
  • People who are unable to commit to the daily mindfulness practice of at least 30 minutes
  • People who are currently pregnant or breastfeeding; if a participant becomes pregnant during the study, their participation would need to end
  • People with serious mental health conditions, such as schizophrenia

There are no exclusions based on national origin, culture, ethnicity, race, sex, physical disability, sexual orientation, religion, or spiritual practices.


Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Peter Hudoba De Badyn, MD, FRCS,, Sha Research Foundation

Phone: 604-904-7712

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sha Research Foundation
Registry
ClinicalTrials.gov
Start date
10 February 2022
Est. completion
31 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean Change from Baseline in Quality of Life Scores on 36-item short-form Quality of Life Questionnaire (SF-36) at 6 weeks; Mean Change from Baseline in Scores on PHQ-9 questionnaire at 6 weeks; Mean Change from Baseline in Scores on BAI-21 (Beck Anxiety Inventory) Scale at 6 weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov